Seizures in Alzheimer disease: who, when, and how common? - Wikidata - awgldk - TriplyDB

Seizures in Alzheimer disease: who, when, and how common?

Seizures in Alzheimer disease: who, when, and how common?

http://www.wikidata.org/entity/Q33157686

about

The causes of new-onset epilepsy and seizures in the elderly DBA/2J genetic background exacerbates spontaneous lethal seizures but lessens amyloid deposition in a mouse model of Alzheimer's disease.Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.Seizures in Alzheimer disease: clinical and epidemiological data.Seizures and epileptiform activity in the early stages of Alzheimer disease Altered theta oscillations and aberrant cortical excitatory activity in the 5XFAD model of Alzheimer's disease.Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer's disease mouse model.Seizures and epilepsy in Alzheimer's disease Apolipoprotein epsilon 3 alleles are associated with indicators of neuronal resilience Chronic temporal lobe epilepsy is associated with enhanced Alzheimer-like neuropathology in 3×Tg-AD mice Molecular changes in brain aging and Alzheimer's disease are mirrored in experimentally silenced cortical neuron networks.Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links.Comorbidities in Neurology: Is adenosine the common link?Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease."Untangling" Alzheimer's disease and epilepsy.Unique biology of gliomas: challenges and opportunities.Incidence of new-onset seizures in mild to moderate Alzheimer disease A Novel Form of Compensation in the Tg2576 Amyloid Mouse Model of Alzheimer's Disease.Promoter Variants of the ADAM10 Gene and Their Roles in Temporal Lobe Epilepsy.Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms.Entorhinal Cortex dysfunction can be rescued by inhibition of microglial RAGE in an Alzheimer's disease mouse model.Early-Onset Network Hyperexcitability in Presymptomatic Alzheimer's Disease Transgenic Mice Is Suppressed by Passive Immunization with Anti-Human APP/Aβ Antibody and by mGluR5 Blockade.The somatic comorbidity of epilepsy: a weighty but often unrecognized burden.Electroencephalogram and Alzheimer's disease: clinical and research approaches.Potential Similarities in Temporal Lobe Epilepsy and Alzheimer’s Disease: From Clinic to Pathology.Neuronal activity and amyloid plaque pathology: an update.Alzheimer's and seizures: interleukin-18, indoleamine 2,3-dioxygenase and quinolinic Acid Overstimulation of the inhibitory nervous system plays a role in the pathogenesis of neuromuscular and neurological diseases: a novel hypothesis.Treatment of epilepsy in patients with Alzheimer's disease.Human astrocytes in the diseased brain.Seizures and epileptiform activity in early Alzheimer disease: how hard should we be looking?Incidence and impact of subclinical epileptiform activity in Alzheimer's disease.Unprovoked seizures in multiple sclerosis: Why are they rare?How important is Alzheimer's disease as a risk factor for unprovoked seizures and epilepsy in the elderly?Alzheimer's disease and epilepsy: insight from animal models.Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia.A perfect storm: Converging paths of epilepsy and Alzheimer's dementia intersect in the hippocampal formation.Temporal lobe epilepsy in the elderly.Nonconvulsive seizures and dementia: a case report.Decreased expression of Gab2 in patients with temporal lobe epilepsy and pilocarpine-induced rat model.

P2860

Q26744349-F885FC62-723F-459D-B31D-289213DCF68E Q30412535-5B1E1C21-4783-43B0-8628-095AB009ED31 Q30493972-D5C9DAA8-E04C-4F25-A539-7A1BBF6F7A18 Q30575767-7CB651FE-6DA4-4AE3-8714-408DB9ABFBAC Q30577633-F3611AE0-93F0-4818-B7B4-40DAB453A7A2 Q30640315-72BF5FA1-A1F5-470C-AF97-3B51DBE0D2F0 Q30647611-E863FAEE-91D1-46EC-8CFD-843E264EE99B Q34070798-15529FC4-7669-4663-B083-82EE11BD2E34 Q34232171-474AA273-283F-4194-86FC-A29A1930C2DB Q34479091-8E3ADA13-4E43-49A3-9CC5-FC49A93B761F Q34524924-C52FC8FB-3D62-415D-982A-337A97138ED3 Q34953710-840BB362-19E9-4199-B169-3BBB85C99DF6 Q35956389-049798D6-2A3C-4D48-A296-08D0F80A0BE0 Q36342218-02780DB4-E842-4195-B942-B6742DCED824 Q36352123-049F0399-E984-4FF3-A42E-F4B0772888A0 Q36626214-E1D8DC0D-4133-4EE2-8EE0-2514D744A07A Q36754121-8C3AAF29-5078-4EE3-B3E2-2D2C35826299 Q37009427-C18C1912-5509-4193-876A-F9ABC0F47DE0 Q37054395-102021FA-FB67-490E-B96E-18BCC0E8B350 Q37583653-3FF059F9-20BD-4663-9805-3BE31EDB14F9 Q37638090-B722F4EA-D477-4F87-8A7B-C8334A27751D Q37719047-B0ECC097-F14F-4398-B883-F33B8B963AE5 Q38018125-56921947-62E4-44C2-B80E-83A3B1944DD2 Q38215516-84E51CFA-3370-4062-BD5A-C94F39C818F7 Q38218353-ED446073-1DA6-4829-A8EB-DAD54D1D4B89 Q38601447-14293E08-2370-417A-91AD-C18298BB445E Q38729027-596AE1B7-552E-48F5-88BC-99EA3EDE9CCA Q38933657-8E2DEB11-613F-4E19-95CB-7434AA6E8D12 Q38968481-6273A773-EB61-44E3-8C6C-00C01B04AA89 Q39141123-B081BBE9-7265-4C52-9C08-DB596FFADD34 Q39256157-386F1754-B032-4A61-B67C-E50DD7949982 Q39328473-04296156-9838-4787-8E77-7DA2FA9C82BD Q39449276-94BC6D1F-FF99-466A-ACB2-C8E82E2F5FC8 Q39553637-36D127A5-03C3-4A14-BCDE-915EB553FF03 Q39598179-7FD2D4F1-3E67-41D8-B442-A8CE83003EBD Q41706435-F7AF1472-BF2A-4A4F-9907-60AAEE9B8911 Q41817650-378109A5-39AE-478F-9D4D-77F636CD6136 Q42279229-7449FADE-33D9-495D-B3F8-129AB6DA495F Q42728774-6D995864-1189-4811-AB63-E36F2465C857 Q43599319-32B7DE0B-67D6-4336-98F5-E805BAA43518

P2860

Seizures in Alzheimer disease: who, when, and how common?

http://www.wikidata.org/entity/Q33157686

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Seizures in Alzheimer disease: who, when, and how common?

@ast

Seizures in Alzheimer disease: who, when, and how common?

@en

type

label

Seizures in Alzheimer disease: who, when, and how common?

@ast

Seizures in Alzheimer disease: who, when, and how common?

@en

prefLabel

Seizures in Alzheimer disease: who, when, and how common?

@ast

Seizures in Alzheimer disease: who, when, and how common?

@en

P1433

Q33157686-7948E14C-9D7C-49EE-9326-4A84520B6134

P1476

Q33157686-633127CA-4766-4717-82C0-246A5B3D6EBD

P2093

Q33157686-008E1FDC-A92B-4BC4-9B59-2305C5E0CF8B

Q33157686-037176FE-13AD-43C7-90D0-3999D778B3EC

Q33157686-2219AA03-1F7B-46F1-B414-7BC4E2737031

Q33157686-52C117B7-E2BE-409E-B723-446D5D7303AD

Q33157686-8B04562C-662C-4CAB-824F-144BC5080EA9

Q33157686-8E49770D-C61F-48E9-AA2E-C0406A642CA8

Q33157686-9D81850F-3F93-4C04-A813-D9094DAC9248

Q33157686-B9A51C30-877B-4F2B-B159-C30F0C9D98C0

P2860

Q33157686-01080A45-DFCB-4412-A7D6-F96B99BC99E0

Q33157686-047386AC-A714-454B-85F8-C09BE76B0B94

Q33157686-0BC48B47-4B8D-4373-AFE3-146FFA4A10B5

Q33157686-0F4E3505-86C5-4723-9FF6-10AAF96E91C3

Q33157686-13C128DB-863A-4A20-87E6-47D752DB343E

Q33157686-24CAD1FD-BAF7-4171-905A-49562238A123

Q33157686-361F99CA-E41F-465B-9BB7-A7429E86905C

Q33157686-3B2FF305-B15C-4373-A065-8D53F4F1B61D

Q33157686-4E6C7A27-F564-47FF-AF89-18BA3A05A990

Q33157686-79320030-9E84-4C0B-8B8D-EBEB0C119A78

P304

Q33157686-B0B24A73-55AD-4F08-BDB1-F0FB698EE6C8

P31

Q33157686-DB8C14F8-1595-40ED-9B73-E791FBE6D168

P356

Q33157686-EF0C5FFB-06F0-448D-A75D-ADD4A889A3D2

P433

Q33157686-4EBB0806-2E2F-4626-8353-FA2C5CEEF0F3

P478

Q33157686-F1892380-80EA-48EA-B0D5-4F008C236E90

P50

Q33157686-8C1E0658-975A-4048-A900-061185967FB8

Q33157686-9765051D-FB84-445F-9225-7DBFE1A5BE57

Q33157686-990FBC48-BDA5-4BC5-8045-1A866965F32F

Q33157686-D75C7269-1D7B-499E-BDB7-A526E347E197

P577

Q33157686-188C7873-6EE1-4DBB-BC2E-05B325BD6AEF

P5875

Q33157686-A24DEB13-3169-4EC4-96CB-49491AF20106

P698

Q33157686-685A0CCA-47CA-476E-8E99-218170CCEE7B

P921

Q33157686-21FC237C-C3FD-4090-900E-BC45D478A970

P932

Q33157686-755463B9-B269-4094-BE8F-843606390285

P356

ARCHNEUROL.2009.130

P1433

P1476

Seizures in Alzheimer disease: who, when, and how common?

@en

P2093

Hyunmi Choi

http://www.w3.org/2001/XMLSchema#string

Joan C Amatniek

http://www.w3.org/2001/XMLSchema#string

Julio Cantero

http://www.w3.org/2001/XMLSchema#string

Karen Bell

http://www.w3.org/2001/XMLSchema#string

Karen Marder

http://www.w3.org/2001/XMLSchema#string

Lawrence S Honig

http://www.w3.org/2001/XMLSchema#string

Nikolaos Scarmeas

http://www.w3.org/2001/XMLSchema#string

W Allen Hauser

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

The Measurement of Observer Agreement for Categorical Data

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease

Practice Parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

APOE-dependent PET patterns of brain activation in Alzheimer disease.

Motor signs during the course of Alzheimer disease.

Delusions and hallucinations are associated with worse outcome in Alzheimer disease

Motor signs predict poor outcomes in Alzheimer disease.

Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease

P304

992-997

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUROL.2009.130

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Deborah Blacker

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26729068

http://www.w3.org/2001/XMLSchema#string

P698

19667221

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2768279

http://www.w3.org/2001/XMLSchema#string